Tyers Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$14.8M Sell
434,218
-85,495
-16% -$3.11M 0.49% 45
2019
Q2
$21.4M Sell
519,713
-47,836
-8% -$1.9M 0.72% 29
2019
Q1
$22.9M Buy
567,549
+43,106
+8% +$1.73M 0.79% 30
2018
Q4
$21.7M Buy
524,443
+53,054
+11% +$2.2M 0.87% 28
2018
Q3
$19.7M Buy
471,389
+38,376
+9% +$1.48M 0.65% 41
2018
Q2
$14.9M Buy
433,013
+18,156
+4% +$620K 0.51% 48
2018
Q1
$14M Buy
414,857
+47,327
+13% +$1.63M 0.49% 53
2017
Q4
$12.6M Buy
367,530
+69,518
+23% +$2.37M 0.44% 58
2017
Q3
$10.1M Buy
298,012
+49,112
+20% +$1.58M 0.37% 64
2017
Q2
$7.93M Buy
248,900
+54,260
+28% +$1.71M 0.29% 84
2017
Q1
$6.32M Buy
194,640
+57,437
+42% +$1.81M 0.24% 84
2016
Q4
$4.23M Buy
+137,203
New +$4.19M 0.18% 107

Other funds holding PFE

Tyers Asset Management's PFE Position: Q3 2019 in Review

Tyers Asset Management reduced its Pfizer (PFE) stake by 16% in Q3 2019, selling an estimated $3.11M and leaving 434,218 shares worth $14.8M. The position accounts for 0.49% of the portfolio, ranked #45.

Tyers Asset Management first reported a position in PFE in Q4 2016 and has held it in 12 quarters since. The position peaked at $22.9M in Q1 2019. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Tyers Asset Management held 434,218 shares of Pfizer worth $14.8M as of Q3 2019.
  • Tyers Asset Management sold 85,495 Pfizer shares in Q3 2019, an estimated $3.11M.
  • Pfizer made up 0.49% of Tyers Asset Management's portfolio in Q3 2019, its #45 holding.
  • Tyers Asset Management first reported a position in Pfizer in Q4 2016 and has held it in 12 quarters since.
  • Tyers Asset Management's Pfizer position peaked at $22.9M in Q1 2019.
  • 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.